Evidence map›Paper›PMID 20804152›Full record

ArticleBiochemistry2010

Positions 94-98 of the lactose repressor N-subdomain monomer-monomer interface are critical for allosteric communication.

Hongli Zhan, Maricela Camargo, Kathleen S Matthews

Abstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Experimental evolution and proximate mechanisms in biology.Synthetic and systems biotechnology · 2017
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hongli ZhanDepartment of Biochemistry and Cell Biology, Rice University, MS-140, 6100 South Main Street, Houston, Texas 77005, USA.
Maricela Camargo
Kathleen S Matthews

Funding

PHYSICAL AND GENETIC STUDIES OF REPRESSOR PROTEINSR01GM022441 · NIGMS · RICE UNIVERSITY · PI MATTHEWS, KATHLEEN S · 1985 to 2009
$1.7M
NIGMS NIH HHS GM22441NIGMS NIH HHS R01 GM022441
6 · The paper itself

Abstract

The central region of the LacI N-subdomain monomer-monomer interface includes residues K84, V94, V95, V96, S97, and M98. The side chains of these residues line the β-strands at this interface and interact to create a network of hydrophobic, charged, and polar interactions that significantly rearranges in different functional states of LacI. Prior work showed that converting K84 to an apolar residue or converting V96 to an acidic residue impedes the allosteric response to inducer. Thus, we postulated that a disproportionate number of substitutions in this region of the monomer-monomer interface would alter the complex features of the LacI allosteric response. To explore this hypothesis, acidic, basic, polar, and apolar mutations were introduced at positions 94-98. Despite their varied locations along the β-strands that flank the interface, ∼70% of the mutations impact allosteric behavior, with the most significant effects found for charged substitutions. Of note, many of the LacI variants with minor functional impact exhibited altered stability to urea denaturation. The results confirm the critical role of amino acids 94-98 and indicate that this N-subdomain interface forms a primary pathway in LacI allosteric response.

Indexed as

Allosteric RegulationDNAEscherichia coliEscherichia coli ProteinsLac RepressorsModels, MolecularMutationProtein BindingProtein StabilityProtein Structure, TertiaryProtein UnfoldingDNAEscherichia coli ProteinsLacI protein, E coliLac Repressors

Identifiers

PMID20804152
PMCPMC3006071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.